StoxGud Sign in

Sumitomo Chemical India vs Anupam Rasayan India: share price & financials comparison

NSE: SUMICHEM vs ANURAS · Chemicals · as of 13 Nov 2026

Sumitomo Chemical IndiaNSE: SUMICHEM₹346.60 -2.82%Neutral setup · 5/10vsAnupam Rasayan IndiaNSE: ANURAS₹1,300.60 +8.22%Neutral setup · 5/10

Both prices rebased to 100 at the start of the selected period.

Sumitomo Chemical India vs Anupam Rasayan India at a glance

Sumitomo Chemical India (SUMICHEM) has a market capitalisation of ₹17,300 Cr, against ₹14,807 Cr for Anupam Rasayan India (ANURAS). Over the past year Anupam Rasayan India has returned +21.0%, compared with -30.6% for Sumitomo Chemical India. On valuation, Sumitomo Chemical India trades at a lower P/E of 31.0 versus 82.1. Sumitomo Chemical India earns a higher return on equity (15.1% vs 3.6%). Sumitomo Chemical India comes out ahead on size, valuation, profitability and financial health. Anupam Rasayan India comes out ahead on growth, momentum and technicals. Across the scored metrics below, Sumitomo Chemical India leads on 6 and Anupam Rasayan India on 11. On StoxGud's 10-point checklist, Sumitomo Chemical India scores 5/10 and Anupam Rasayan India scores 5/10.

MetricSumitomo Chemical IndiaAnupam Rasayan India
Size
Market cap₹17,300 Cr₹14,807 Cr
Revenue (latest FY)₹3,238 Cr₹2,365 Cr
Net profit (latest FY)₹543 Cr₹170 Cr
Valuation
P/E31.082.1
P/B4.682.93
Dividend yield0.35%0.10%
Profitability
Return on equity15.1%3.6%
Net profit margin17.3%6.9%
Operating margin20.3%23.5%
Growth
Revenue growth (YoY)-2.4%+10.2%
Net profit growth (YoY)-11.5%+12.7%
Revenue CAGR (multi-year)+4.9%+23.9%
Financial health
Debt to equity0.000.49
Momentum
1-month return-16.3%+11.6%
1-year return-30.6%+21.0%
3-year CAGR-3.3%+12.3%
5-year CAGR-1.3%+9.5%
Distance from 52W high-38.6%-5.5%
Technicals
RSI (14)4483
Price vs 200-day avg-22.2%+3.9%

Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.

10-point checklist side by side

CheckSumitomo Chemical IndiaAnupam Rasayan India
Price above 50-day average✗✓
Price above 200-day average✗✓
50-day average above 200-day (uptrend)✗✗
RSI in healthy 40–70 zone✓✗
Positive 1-year return✗✓
Return on equity above 15%✓✗
Debt to equity below 1✓✓
Revenue growing year on year✗✓
Net profit margin above 10%✓✗
P/E below industry median✓✗
Score5/105/10

A rules-based screen for education only — not a buy or sell recommendation.

FAQs

Which is bigger, Sumitomo Chemical India or Anupam Rasayan India?

Sumitomo Chemical India has a market cap of ₹17,300 Cr and Anupam Rasayan India has a market cap of ₹14,807 Cr as of 13 Nov 2026.

Which has a lower P/E, Sumitomo Chemical India or Anupam Rasayan India?

Sumitomo Chemical India has the lower P/E: Sumitomo Chemical India trades at 31.0 and Anupam Rasayan India at 82.1.

Which gave better returns in the last year, Sumitomo Chemical India or Anupam Rasayan India?

Anupam Rasayan India did better: Sumitomo Chemical India returned -30.6% and Anupam Rasayan India returned +21.0% over one year.

What is the difference between Sumitomo Chemical India and Anupam Rasayan India?

Both are NSE-listed companies in Chemicals. Sumitomo Chemical India is about 1.2 times the size of Anupam Rasayan India by market cap. In the latest financial year Sumitomo Chemical India reported revenue of ₹3,238 Cr and Anupam Rasayan India ₹2,365 Cr. Operating margin is 20.3% for Sumitomo Chemical India and 23.5% for Anupam Rasayan India. Debt to equity is 0.00 for Sumitomo Chemical India and 0.49 for Anupam Rasayan India.

Which is better, Sumitomo Chemical India or Anupam Rasayan India?

It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Sumitomo Chemical India leads on 6 and Anupam Rasayan India on 11. Sumitomo Chemical India is ahead on size, valuation, profitability and financial health. Anupam Rasayan India is ahead on growth, momentum and technicals. On StoxGud's rules-based checklist Sumitomo Chemical India scores 5/10 and Anupam Rasayan India scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.

More comparisons